Bone Health in Patients With Prostate Cancer: An Evidence-Based Algorithm

Area of Science:

• Oncology
• Geriatrics
• Bone Metabolism

Background:

• Prostate cancer affects a significant portion of the veteran population.
• Long-term androgen deprivation therapy (ADT) is a standard treatment for advanced prostate cancer.
• Survivorship and treatment complications are key concerns in prostate cancer care.

Purpose of the Study:

• To review current research on bone health in men undergoing prostate cancer treatment.
• To present an evidence-based approach for managing bone health complications.
• To provide guidance on monitoring and interventions for bone health during ADT.

Main Methods:

• Literature review of recent studies on prostate cancer and bone health.
• Development of a clinical algorithm for bone health management.
• Analysis of treatment outcomes and risk factors for bone complications.

Main Results:

• Prolonged ADT is associated with significant bone loss and increased fracture risk.
• Bone-modifying agents (bisphosphonates, RANKL inhibitors) reduce fracture risk.
• These agents are crucial for both hormone-naive and castration-resistant prostate cancer patients with bone involvement.

Conclusions:

• Bone health complications are a critical consideration in long-term prostate cancer management.
• An evidence-based algorithm can guide monitoring and intervention strategies.
• Proactive bone health management improves survivorship and reduces mortality in prostate cancer patients.